Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

16.930
-0.380-2.20%
Volume:995.50K
Turnover:16.92M
Market Cap:45.02B
PE:11.42
High:17.360
Open:17.280
Low:16.860
Close:17.310
52wk High:28.232
52wk Low:14.505
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:5.42
T/O Rate:0.18%
Dividend:0.45
Dividend Rate:2.66%
EPS(LYR):1.482
ROE:7.04%
ROA:1.53%
PB:0.78
PE(LYR):11.42
PS:0.91

Loading ...

Fosun Pharma Secures Shareholder Support for All AGM Proposals; Announces RMB0.39 Final Dividend

Bulletin Express
·
Jun 16

Fosun Pharma Unit's Luvometinib Gets China Nod for Langerhans Cell Histiocytosis Drug Indication

MT Newswires Live
·
Jun 16

Fosun Pharma Showcases Strategy at Abu Dhabi Forum, Highlighting Innovation and Collaboration as Key to China-UAE Healthcare Partnership

Deep News
·
Jun 15

Fosun Pharma secures NMPA nod for Luvometinib’s pediatric LCH indication, lifting rare-tumor portfolio

Bulletin Express
·
Jun 15

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets Approved by Nmpa

THOMSON REUTERS
·
Jun 15

Fosun Pharma's Shareholder Meeting Hints at Major Moves: Billions in Guarantees and Dual A/H Share Buybacks Revealed

Deep News
·
Jun 13

Sinopharm Group Stock Falls 1.6% in Hong Kong

Dow Jones
·
Jun 11

FOSUN INTL's "Strongest Valuation Anchor" Solidifies as Innovative Drug R&D and Commercialization Accelerates

Stock News
·
Jun 03

Subsidiary of FOSUN PHARMA Gains Approval for Pertuzumab Injection

Stock News
·
May 29

FOSUN PHARMA Invests Over 400 Million Yuan in Nucleic Acid Drug Firm

Deep News
·
May 27

Sinopharm Group Stock Falls 1.7% in Hong Kong

Dow Jones
·
May 27

Fosun Pharmaceutical to Invest 414 Million Yuan in Xingyao Kunze's Series B Funding Round

MT Newswires Live
·
May 27

Fosun Pharma Gets Registration Nod for Infection Drug in China

MT Newswires Live
·
May 21

Fosun Pharma receives NMPA clearance for Yaopharma-developed Levofloxacin Injection

Bulletin Express
·
May 21

FOSUN PHARMA Subsidiary Gains Approval for Levofloxacin Injection

Stock News
·
May 21

Shanghai Fosun Pharma - Drug Registration Application for Levofloxacin Injection Approved by China's Nmpa

THOMSON REUTERS
·
May 21

FOSUN PHARMA Subsidiary's HLX3902 Injection Approved for Clinical Trials in Australia

Stock News
·
May 21

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21

Sinopharm Group Stock Falls 2.1% in Hong Kong

Dow Jones
·
May 18

FOSUN PHARMA's Strategic Move: $60 Million Secures Potential Over $2.5 Billion for AR1001

Stock News
·
May 14